Bio
Tamiko Katsumoto, MD, is a Clinical Assistant Professor in the Division of Immunology and Rheumatology at Stanford University. She earned her MD from the University of California, San Francisco. She completed her internal medicine residency and rheumatology fellowship at UCSF, including a postdoc in the immunology lab of Dr. Arthur Weiss. Dr. Katsumoto’s research interests include the discovery of novel biomarkers to predict the development of immune-related adverse events in cancer patients on immune checkpoint inhibitor therapies, and optimizing the management of such complications. She serves as the director of the Stanford Immune Related Toxicity Working Group, a multidisciplinary group which aims to improve the quality of care of patients on checkpoint inhibitors. She is fascinated by the relationship between cancer and autoimmune diseases such as scleroderma and dermatomyositis, and the paraneoplastic manifestations of various cancers. She has spent time at Genentech, where she led several clinical trials in immunology.
